FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horses
FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horses
FDAQRC
Private
Quality & Regulatory Consultants
Company Info
Recent News
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer